Sally Beauty Holdings (SBH) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
7 Aug, 2026Executive summary
Q3 net sales were $935–$935.5 million, up 0.2% year-over-year, with comparable sales flat and results within guidance.
Adjusted diluted EPS was $0.55, up 8% year-over-year; GAAP diluted EPS increased 25%.
Cash flow from operations reached $80.9–$81 million, supporting investments, debt repayment, and share repurchases.
Sally U.S. and Canada drove growth with 3.5% comparable sales increase, while BSG faced softness.
Operates over 4,300 stores globally, serving both consumer and professional beauty markets with omni-channel capabilities.
Financial highlights
Gross margin expanded 90 bps to 52.4% (GAAP); adjusted gross margin up 40 bps to 52.4%.
Adjusted operating income was $87 million; operating margin improved to 9.2%.
Sally segment net sales grew 2.2% to $538.6–$539 million; BSG segment net sales declined 2.4% to $396.9–$397 million.
Cash and equivalents at quarter end were $173–$173.1 million; free cash flow was $62 million.
Net earnings for Q3 were $54.1 million, up 18.3% year-over-year.
Outlook and guidance
FY26 consolidated net sales expected at $3.725–$3.733 billion, with comparable sales up ~0.5%.
Adjusted operating earnings forecasted at $329–$335 million; adjusted diluted EPS at $2.04–$2.08.
Capital expenditures and free cash flow guidance unchanged at ~$100 million and ~$200 million, respectively.
At least 50% of free cash flow to be allocated to share repurchases.
Latest events from Sally Beauty Holdings
- Growth fueled by innovation, digital expansion, and strong financials in beauty retail and distribution.SBH
Canaccord Genuity's 46th Annual Growth Conference - Q2 net sales up 2.3%, margins expanded, cash flow strong, Sally segment led growth.SBH
Q2 2026 - Adjusted EPS up 12% as net sales rose 0.6% and FY26 guidance was raised.SBH
Q1 2026 - Strong Q4 and FY results, margin expansion, and robust cash flow support double-digit EPS growth.SBH
Q4 2025 - Operating margin and EPS rose as guidance was raised, despite lower sales and macro uncertainty.SBH
Q3 2025 - Q4 and FY24 saw comp sales growth, margin gains, and a positive outlook for 2025.SBH
Q4 2024 - Q3 sales up 1.2%, but net earnings fell 25.8% amid margin and interest pressures.SBH
Q3 2024 - Operating margin and EPS rose despite a 2.8% sales decline and macro headwinds.SBH
Q2 2025 - Sales and margins grew, net earnings surged, and liquidity remained strong in Q1.SBH
Q1 2025